I'm sure these drugs make you get a swift recovery from COVID-19.
Here is the overview of Pyramax.

1. An fixed-dose combination of pyronaridine tetraphosphate and artesunate, designated in FDA as an Orpha drug on 09/27/2018 as an antimalarial drug.

2. Developed and Sponsered by Shin Poong Pharmaceutical Co., Ltd.
161 Yoksam-Ro, Gangnam-Gu,Seoul, South Korea
+82-2-2189-3400

3. Co-sponsored by MMV(Medicine for Malaria Venture)
+41-22-555-03-00

4. Under phase II clinical trial for repurposing to COVID-19 in South Korea and South Africa.
- ClinicalTrials.gov Identifier: NCT04475107 :The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
- ClinicalTrials.gov Identifier: NCT04532931 :COVID-19 Treatment in South Africa

5. Showed the effect of suppressing SARS-CoV-2 100% in the in-vitro test.

свернуть